Skip to main content
Clinical Trials/NL-OMON46749
NL-OMON46749CompletedNot Applicable

The effects of nutritional supplements on postprandial nitric oxide bioactivity in abdominally obese men - Nutritional supplements and nitric oxide bioactivity

Medisch Universitair Ziekenhuis Maastricht0 sites20 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Aged between 40-70 years
  • - Waist circumference >= 102
  • - Fasting plasma glucose < 7.0 mmol/L
  • - Fasting serum total cholesterol < 8.0 mmol/L
  • - Stable body weight (weight gain or loss < 3 kg in the past three months)
  • - Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
  • - No difficult venipuncture as evidenced during the screening visit
  • - No current smoker
  • - No diabetic patients
  • - No familial hypercholesterolemia
  • - No abuse of drugs
  • - No more than 3 alcoholic consumptions per day
  • - No use of medication known to treat blood pressure, lipid or glucose metabolism
  • - No use of an investigational product within another biomedical intervention trial within the previous 1-month
  • - No intolerance or allergy to the ingredients of the intervention products (e.g. lactose or gluten)
  • - No severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
  • - No active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
  • - Willingness to give up the use of antibacterial mouth wash or antibacterial toothpaste, chewing-gum and tongue-scraping on the morning of each experimental test day

Exclusion Criteria

  • - Fasting plasma glucose >= 7.0 mmol/L
  • - Fasting serum total cholesterol >= 8.0 mmol/L
  • - Current smoker, or smoking cessation <12 months
  • - Diabetic patients
  • - Familial hypercholesterolemia
  • - Abuse of drugs
  • - More than 3 alcoholic consumptions per day
  • - Unstable body weight (weight gain or loss > 3 kg in the past three months)
  • - Use medication known to treat blood pressure, lipid or glucose metabolism
  • - Use of an investigational product within another biomedical intervention trial within the previous 1-month
  • - Intolerance or allergy to the intervention products (e.g. lactose or gluten)
  • - Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
  • - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
  • - Not willing to give up being a blood donor from 8 weeks before the start of the study, during the study or for 4 weeks after completion of the study
  • - Not or difficult to venipuncture as evidenced during the screening visit

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Similar Trials

The effects of nutritional supplements on... | Clinical Trial